London, UK / Copenhagen, Denmark – 2026
NADclinic, a global provider of NAD+ therapeutics and performance medicine services, and BioAgeDiagnostics, a precision diagnostics platform and authorised distributor of Generation Lab’s SystemAge™ biological age test, have announced a strategic collaboration aimed at advancing data-driven longevity medicine across Europe and selected international markets.
The collaboration brings together advanced biological age diagnostics and NADclinic’s curated portfolio of NAD+ therapeutics and performance medicine protocols, supporting a more structured and measurable approach to personalised health optimisation.
From Intuition to Precision Longevity
For decades, longevity medicine has been guided largely by clinical experience and wellness protocols. Today, the field is rapidly transitioning toward biomarker-driven, algorithmic medicine, where biological ageing can be measured, interpreted and addressed with increasing precision.
The collaboration between NADclinic and BioAgeDiagnostics reflects this broader industry shift toward data-driven longevity care.
Initial discussions around the collaboration began during WHX Labs Dubai, where leaders from NADclinic, Generation Lab and BioAgeDiagnostics explored how advanced diagnostics and targeted longevity interventions could be integrated into a more structured clinical framework.
At the centre of this approach is SystemAge™, Generation Lab’s biological age platform.
The test analyses more than 460 biomarkers across 19 physiological systems, enabling clinicians to understand how ageing progresses across multiple organ systems rather than relying on a single biological age metric.
A New Model for Personalised Longevity Care
“Longevity medicine will not be built on intuition. It will be built on data, algorithms and precision,” said Iain De Havilland, CEO of NADclinic.
“The sophistication of Generation Lab’s biological age and multi-system biomarker platform is extremely impressive. Aligning advanced diagnostics with our therapeutic portfolio allows us to move closer to a truly data-driven longevity model across our clinical networks.”
The collaboration aims to support a more structured longevity framework built around four core components:
Advanced Diagnostics
Multi-system biological age testing providing insight into physiological ageing dynamics and resilience capacity.
Biomarker Analytics
Algorithmic analysis identifying early physiological stress signals and accelerated ageing patterns before clinical symptoms appear.
Targeted Therapeutics
Clinically guided longevity protocols including NAD+ therapies and performance medicine strategies tailored to individual biological profiles.
Continuous Optimisation
Longitudinal biomarker tracking enabling measurable healthspan monitoring over time.
Building the Infrastructure for Precision Longevity
According to Bettina van Wylich-Muxoll, Managing Director of BioAgeDiagnostics, the next phase of longevity medicine will depend on the ability to operationalise precision diagnostics across clinical networks.
“Epigenetic intelligence reveals biological state, resilience capacity and system-level ageing dynamics. We are very pleased to make NADclinic’s curated portfolio of NAD+ therapeutics and performance medicine solutions available to our customers. Our role is to provide the infrastructure that enables healthcare providers to integrate diagnostics with targeted interventions in a scalable and compliant way.”
BioAgeDiagnostics operates as a B2B clinical infrastructure partner, enabling healthcare providers and medical spas to operationalise longevity medicine through integrated diagnostics, curated therapeutics and protocol frameworks.
The platform provides clinical partners with access to:
-
advanced biological age diagnostics including SystemAge™
-
genetic and metabolic testing platforms
-
NAD+ therapeutics and metabolic performance solutions
-
IV formulations, peptides and longevity supplements within regulated frameworks
Rather than delivering patient care directly, BioAgeDiagnostics focuses on enabling healthcare providers to deliver data-driven longevity services at scale.
About NADclinic
NADclinic is a global provider of NAD+ therapeutics and performance medicine services, delivering clinically structured longevity and health optimisation protocols through an international network of clinics and practitioners.
About BioAgeDiagnostics
BioAgeDiagnostics is a specialised B2B precision longevity platform providing healthcare providers with integrated access to advanced biological age testing and genetic diagnostics, alongside a curated portfolio of therapeutics, peptides, NAD+ formulations and metabolic performance solutions.
The company functions as a clinical infrastructure partner enabling healthcare providers to deliver precision longevity medicine at scale.
